Editorial

DOI: 10.4244/EIJ-E-24-00023

New-onset or newly detected atrial fibrillation after transcatheter aortic valve implantation?

George C.M. Siontis1, MD, PhD; Stephan Windecker1, MD

Diagnosis of new-onset atrial fibrillation (AF) in elderly patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) has important acute and long-term implications in clinical decision-making. In this issue of EuroIntervention, Nuche et al1 report the results of a multicentre study in patients with severe aortic stenosis and no previously known AF undergoing TAVI who were monitored by means of different methods of continuous ambulatory electrocardiogram (ECG) recording devices. The analysis was conducted retrospectively on prospectively collected data. New-onset AF was detected in 7% of the patients and resulted in the initiation of long-term oral anticoagulation therapy in half of these patients; it was not associated with impaired clinical outcomes up to 1 year of follow-up.

This study is published at a time when the widespread adoption of continuous rhythm monitoring devices has facilitated the identification of individuals with non-clinically overt manifestations of AF, leading to the recognition of a new entity within the AF spectrum called subclinical AF. The prevalence of subclinical AF increases with advancing age and may be as high as 30%,...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 9
May 10, 2024
Volume 20 Number 9
View full issue


Key metrics

Suggested by Cory

Debate

10.4244/EIJ-E-22-00043 Nov 18, 2022
TAVI in asymptomatic patients with severe aortic stenosis: pros and cons
Généreux P and Iung B
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA7 Sep 18, 2016
Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?
Chakravarty T et al
free

Viewpoint

10.4244/EIJ-D-24-00205 Jul 15, 2024
Subclinical leaflet thrombosis: should we be concerned?
Dangas G and Bay B
free

10.4244/EIJV8I1A4 May 15, 2012
Embolic protection devices during TAVI – the “proof of the pudding”
Van Mieghem NM and Serruys PW
free

EXPERT REVIEW

10.4244/EIJ-D-18-00454 Sep 7, 2018
TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy
Lansky AJ et al
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved